Quantbot Technologies LP Sells 45,338 Shares of Aspen Aerogels, Inc. $ASPN

Key Points

• Quantbot Technologies LP has significantly reduced its stake in Aspen Aerogels, Inc. by 70.1%, now holding just 19,334 shares worth approximately $124,000.
• Institutional investors now control 97.64% of Aspen Aerogels' stock, with notable increases from firms like Millennium Management LLC, which boosted their stake by 4,757.8%.
• Aspen Aerogels recently reported a quarterly earnings of -$0.04 per share, outperforming analysts' expectations, but its revenue fell 33.8% compared to the same quarter last year.

Quantbot Technologies LP lowered its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 70.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,334 shares of the construction company's stock after selling 45,338 shares during the period. Quantbot Technologies LP's holdings in Aspen Aerogels were worth $124,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of ASPN. Banque Cantonale Vaudoise purchased a new position in shares of Aspen Aerogels in the first quarter worth about $45,000. Exchange Traded Concepts LLC increased its holdings in Aspen Aerogels by 460.4% during the 1st quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock valued at $48,000 after purchasing an additional 6,109 shares during the period. CWM LLC increased its holdings in Aspen Aerogels by 2,137.9% during the 1st quarter. CWM LLC now owns 8,325 shares of the construction company's stock valued at $53,000 after purchasing an additional 7,953 shares during the period. Teacher Retirement System of Texas purchased a new position in Aspen Aerogels during the 1st quarter valued at about $65,000. Finally, Sandia Investment Management LP purchased a new position in Aspen Aerogels during the 4th quarter valued at about $89,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Price Performance

Shares of ASPN traded down $0.13 during midday trading on Monday, hitting $6.83. 1,079,251 shares of the company traded hands, compared to its average volume of 2,428,220. The firm has a 50 day moving average of $7.01 and a 200-day moving average of $6.57. Aspen Aerogels, Inc. has a 52 week low of $4.16 and a 52 week high of $30.24. The stock has a market cap of $562.52 million, a price-to-earnings ratio of -1.79 and a beta of 2.65. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.08. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The business had revenue of $78.02 million during the quarter, compared to the consensus estimate of $72.53 million. During the same quarter in the prior year, the firm earned $0.21 EPS. The business's revenue was down 33.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. On average, analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Insider Activity at Aspen Aerogels

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the transaction, the chief accounting officer owned 19,879 shares of the company's stock, valued at approximately $145,315.49. This trade represents a 18.16% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.40% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on ASPN. Barclays downgraded Aspen Aerogels from an "equal weight" rating to an "underweight" rating and boosted their price target for the company from $7.00 to $16.00 in a report on Monday, August 11th. Canaccord Genuity Group cut their price objective on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Finally, Oppenheimer cut Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $19.50.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.